Prelude Therapeutics Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wilmington, DE
SEC filing record 1 source field available
Fiscal year end
31 December
Prelude Therapeutics Inc has filed 386 SEC EDGAR filings since 11 Jul 2016

SEC filing history

Showing 151-175 of 386 matching filings.

Per page
25
Current page
7
4

FORM 4 SUBMISSION

Filing date
13 Dec 2023
Reporting date
13 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91717

SCHEDULE 13G

Filing date
13 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Oct 2023
Reporting date
04 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2023
Reporting date
04 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 May 2023
Reporting date
24 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 May 2023
Reporting date
24 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 May 2023
Reporting date
23 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 May 2023
Reporting date
23 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 May 2023
Reporting date
22 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 May 2023
Reporting date
22 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91717

AMENDMENT NO. 2

Filing date
24 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91717

SC 13D/A

Filing date
24 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .